PATENT CLAIM ANALYSIS

Application Number: 16307362
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "252160"]

Abstract:
The present invention relates to the fused pyrimidine piperidine cyclic derivative represented by the following formula (I) and a pharmaceutically acceptable salt thereof and a process for preparing the same, wherein R1, R2, R3, R4, R5, X, Y and Z are defined as in the description. The present invention further provides use of said fused pyrimidine piperidine cyclic derivative in manufacture of a medicament for preventing or treating FGFR kinase mediated disease such as cancer.

Claim (Index 15):
A pharmaceutical composition, comprising the compound represented by formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.43333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15047892', '14511326', '13394525', '14132653', '14402198']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7451439705448588
- 35 USC 102 Novelty (BERT): 0.5252635436107194
- Combined Prediction Score: 0.7231559278514449
- Mean Citation Score: 331.866862
- Max Citation Score: 336.3714
- Similarity Product: 294.43368229272363

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test